Clinical Research Directory
Browse clinical research sites, groups, and studies.
Refine and Assess the Readability of Patient, Carer, and Clinician Treatment Preference in Myelodysplasia Questionnaire
Sponsor: Otsuka Australia Pharmaceutical Pty Ltd
Summary
The primary goal of this study is to use qualitative interviews to elicit and confirm concepts related to treatment preferences and understandability of the pTPMQ, cTPMQ, and mTPMQ. The information gathered will be used to support the appropriateness of the questionnaires as a patient-reported, caregiver-reported and clinician-reported outcome measure (PROM) in the population of interest.
Official title: Qualitative Interviews to Refine and Assess the Importance of Constructs, and Ensure the Readability of Patient, Carer, and Clinician Versions of the Treatment Preference in Myelodysplasia Questionnaire (TPMQ): pTPMQ, cTPMQ, and mTPMQ, Respectively
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
16
Start Date
2022-06-28
Completion Date
2023-03-10
Last Updated
2026-10-29
Healthy Volunteers
No
Conditions
Interventions
Carer Treatment Preference Myelodysplasia Questionnaire
Caregiver-reported outcome measure in MDS
Clinician Treatment Preference Myelodysplasia Questionnaire
Clinician-reported outcome measure in MDS
Patient Treatment Preference Myelodysplasia Questionnaire
Patient-reported outcome measure (PROM) in MDS
Locations (1)
Calvary Mater Newcastle
Newcastle, New South Wales, Australia